BridgeBio Pharma, Inc. (BBIO)

68.14 -2.58 (-3.65%) USD  |  NASDAQ  |  Feb 20, 16:00
68.70 +0.56 (+0.82%) After-Hours: 20:00
More

BridgeBio Pharma Non-Current Portion of Long Term Debt (Quarterly)

Non-Current Portion of Long Term Debt (Quarterly) Chart

View Non-Current Portion of Long Term Debt (Quarterly) for BBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Non-Current Portion of Long Term Debt (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Non Current Portion of Debt Definition

View Non Current Portion of Debt Definition
Start Trial

Non-current portion of debt that a company owns. Think of this as a component of what a company has for debt that is not a short-term obligation.

Read full definition.

Non-Current Portion of Long Term Debt (Quarterly) Range, Past 5 Years

View Non-Current Portion of Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Non-Current Portion of Long Term Debt (Quarterly) Benchmarks

View Non-Current Portion of Long Term Debt (Quarterly) Benchmarks
Start Trial
Insmed, Inc. Upgrade
Mirum Pharmaceuticals, Inc. Upgrade
Cogent Biosciences, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade